GI
IONS icon

GAMMA Investing’s Ionis Pharmaceuticals IONS Stock Holding History

GAMMA Investing’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172K Buy
2,168
+402
+23% +$30.3K 0.01% 1382
2026
Q1 		$133K Buy
1,766
+33
+2% +$2.6K 0.01% 1438
2025
Q4 		$137K Buy
1,733
+392
+29% +$29.5K 0.01% 1338
2025
Q3 		$87.7K Buy
1,341
+411
+44% +$20.1K ﹤0.01% 1594
2025
Q2 		$36.7K Sell
930
-31
-3% -$1.01K ﹤0.01% 2112
2025
Q1 		$29K Buy
961
+215
+29% +$7.04K ﹤0.01% 2178
2024
Q4 		$26.1K Buy
746
+82
+12% +$3.06K ﹤0.01% 2123
2024
Q3 		$26.6K Buy
664
+303
+84% +$14.1K ﹤0.01% 1931
2024
Q2 		$17.2K Sell
361
-251
-41% -$10.3K ﹤0.01% 1951
2024
Q1 		$26.5K Buy
612
+112
+22% +$5.34K 0.01% 1446
2023
Q4 		$25.7K Buy
+500
New +$23.9K 0.01% 1328

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

GAMMA Investing's IONS Position: Q2 2026 in Review

GAMMA Investing increased its Ionis Pharmaceuticals (IONS) stake by 23% in Q2 2026, buying an estimated $30.3K and bringing the position to 2,168 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #1382.

GAMMA Investing first reported a position in IONS in Q4 2023 and has held it in 11 quarters since. 41 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • GAMMA Investing held 2,168 shares of Ionis Pharmaceuticals worth $172K as of Q2 2026.
  • GAMMA Investing bought 402 Ionis Pharmaceuticals shares in Q2 2026, an estimated $30.3K.
  • Ionis Pharmaceuticals made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1382 holding.
  • GAMMA Investing first reported a position in Ionis Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 41 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.